A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT02087423. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II,Non-comparative,Open Label, Multi-centre, International Study of MEDI4736, in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer (Stage IIIB-IV) Who Have Received at Least 2 Prior Systemic Treatment Regimens Including 1 Platinum-based Chemotherapy Regimen
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer in terms of efficacy, safety and tolerability
Study identification
- NCT ID
- NCT02087423
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 446 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 24, 2014
- Primary completion
- Jun 2, 2016
- Completion
- Mar 25, 2025
- Last update posted
- Apr 5, 2026
2014 – 2025
United States locations
- U.S. sites
- 28
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Goodyear | Arizona | 85338 | — |
| Research Site | Santa Rosa | California | 95403 | — |
| Research Site | New Haven | Connecticut | 06511 | — |
| Research Site | Port Saint Lucie | Florida | 34952 | — |
| Research Site | Tampa | Florida | 33612 | — |
| Research Site | Lawrenceville | Georgia | 30046 | — |
| Research Site | Waterloo | Iowa | 50701 | — |
| Research Site | Topeka | Kansas | 66606 | — |
| Research Site | Bethesda | Maryland | 20817 | — |
| Research Site | Burlington | Massachusetts | 01803 | — |
| Research Site | Worcester | Massachusetts | 01608 | — |
| Research Site | Saint Louis Park | Minnesota | 55426 | — |
| Research Site | New York | New York | 10011 | — |
| Research Site | New York | New York | 10016 | — |
| Research Site | New York | New York | 10032 | — |
| Research Site | New York | New York | 10065 | — |
| Research Site | The Bronx | New York | 10461 | — |
| Research Site | Huntersville | North Carolina | 28078 | — |
| Research Site | Bismarck | North Dakota | 58501 | — |
| Research Site | Fargo | North Dakota | 58102 | — |
| Research Site | Blue Ash | Ohio | 45242 | — |
| Research Site | Canton | Ohio | 44718 | — |
| Research Site | Middletown | Ohio | 45042 | — |
| Research Site | Chattanooga | Tennessee | 37404 | — |
| Research Site | Nashville | Tennessee | 37203 | — |
| Research Site | Fort Worth | Texas | 76104 | — |
| Research Site | Spokane | Washington | 99208 | — |
| Research Site | Wenatchee | Washington | 98801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 111 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02087423, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 5, 2026 · Synced Sep 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02087423 live on ClinicalTrials.gov.